Drosophila TDP-43 dysfunction in glia and muscle cells cause cytological and behavioural phenotypes that characterize ALS and FTLD

Human Molecular Genetics

Volumn 22, Issue 19, 2013, Pages 3883-3893

  Diaper, Danielle C ^a   Adachi, Yoshitsugu ^a   Lazarou, Luke ^a   Greenstein, Max ^a   Simoes, Fabio A ^a   Di Domenico, Angelique ^a   Solomon, Daniel A ^a   Lowe, Simon ^a   Alsubaie, Rawan ^a   Cheng, Daryl ^a   Buckley, Stephen ^a   Humphrey, Dickon M ^a   Shaw, Christopher E ^a   Hirth, Frank ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EXCITATORY AMINO ACID TRANSPORTER 1; GLUTAMATE TRANSPORTER; TAR DNA BINDING PROTEIN;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOLOGY; DROSOPHILA; FRONTOTEMPORAL DEMENTIA; GLIA; MUSCLE CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEPLETION; SARCOPLASMIC RETICULUM; ZEBRA FISH;

AGING; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; ANIMALS, GENETICALLY MODIFIED; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; DROSOPHILA MELANOGASTER; DROSOPHILA PROTEINS; EXCITATORY AMINO ACID TRANSPORTER 1; EXCITATORY AMINO ACID TRANSPORTER 2; FRONTOTEMPORAL LOBAR DEGENERATION; HUMANS; LARVA; MICE; MOTOR ACTIVITY; MUSCLE CELLS; NEUROGLIA; PHENOTYPE;

EID: 84888807206     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddt243     Document Type: Article

References (62)

1. Van Langenhove, T., van der Zee, J. and Van Broeckhoven, C. (2012) The molecular basis of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum. Ann. Med., 44, 817-828.
2. Pasinelli, P. and Brown, R.H. (2006) Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat. Rev. Neurosci., 7, 710-723.
3. Hardiman, O., van den Berg, L.H. and Kiernan, M.C. (2011) Clinical diagnosis and management of amyotrophic lateral sclerosis. Nat. Rev. Neurol., 7, 639-649.
4. Belzil, V.V., Gendron, T.F. and Petrucelli, L. (2013) RNA-mediated toxicity in neurodegenerative disease. Mol. Cell Neurosci. (in press).
5. Mori, K., Weng, S.M., Arzberger, T., May, S., Rentzsch, K., Kremmer, E., Schmid, B., Kretzschmar, H.A., Cruts, M., Van Broeckhoven, C., Haass, C. and Edbauer, D. (2013) The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS. Science, 339, 1335-1338.
6. Ash, P.E.A., Bieniek, K.F., Gendron, T.F., Caulfield, T., Lin, W.L., DeJesus-Hernandez, M., van Bitterswijk, M.M., Jansen-West, K., Paul, J.W. III, Rademakers, R. et al. (2013) Unconventional translation of C9ORF72GGGGCCexpansion generated insoluble polypeptides specific to c9FTD/ALS. Neuron, 77, 597-598.
7. Neumann, M., Sampathu, D.M., Kwong, L.K., Truax, A.C., Micsenyi, M.C., Chou, T.T., Bruce, J., Schuck, T., Grossman, M., Clark, C.M. et al. (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science, 314, 130-133.
8. Arai, T., Hasegawa, M., Akiyama,H., Ikeda, K., Nonaka, T., Mori, H.,Mann, D., Tsuchiya, K., Yoshida, M., Hashizume, Y. and Oda, T. (2006) TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun., 351, 602-611.
9. Chen-Plotkin, A.S., Trojanowski, J.Q. and Lee, V.M. (2010) TAR DNA-binding protein 43 in neurodegenerative disease. Nat. Rev. Neurol., 6, 211-220.
10. Da Cruz, S. and Cleveland, D.W. (2011) Understanding the role of TDP-43 and FUS/TLS in ALS and beyond. Curr. Opin. Neurobiol., 21, 904-919.
11. Lee, E.B., Lee, V.M.Y. and Trojanowski, J.Q. (2012) Gains and losses:molecular mechanisms of TDP43-mediated neurodegeneration. Nat. Rev. Neurosci., 13, 38-50.
12. Ayala, Y.M., Pantano, S., DüAmbrogio, A., Buratti, E., Brindisi, A., Marchetti, C.,Romano,M. and Baralle, F.E. (2005) Human,Drosophila, and C. elegans TDP43: nucleic acid binding properties and splicing regulatory function. J. Mol. Biol., 348, 575-588.
13. Gitler, A.D. and Shorter, J. (2011) RNA-binding proteins with prion-like domains in ALS and FTLD-U. Prion, 5, 179-187.
14. Buratti, E. and Baralle, F.E. (2010) The multiple roles of TDP-43 in pre-mRNA processing and gene expression regulation. RNA Biol., 7, 420-429.
15. Sephton, C.F., Cenik, C., Kucukural, A., Dammer, E.B., Cenik, B., Han, Y., Dewey, C.M., Roth, F.P., Herz, J., Peng, J., Moore, M.J. and Yu, G. (2011) Identification of neuronal RNA targets of TDP-43-containing ribonucleoprotein complexes. J. Biol. Chem., 286, 1204-1215.
16. Tollervey, J.R., Curk, T., Rogelj, B., Briese, M., Cereda, M., Kayikci, M., König, J., Hortobágyi, T., Nishimura, A.L., Zupunski, V. et al. (2011) Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. Nat. Neurosci., 14, 452-458.
17. Polymenidou, M., Lagier-Tourenne, C., Hutt, K.R., Huelga, S.C., Moran, J., Liang, T.Y., Ling, S.C., Sun, E., Wancewicz, E., Mazur, C. et al. (2011) Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat. Neurosci., 14, 459-468.
18. Lagier-Tourenne, C., Polymenidou, M., Hutt, K.R., Vu, A.Q., Baughn, M., Huelga, S.C., Clutario, K.M., Ling, S.C., Liang, T.Y., Mazur, C. et al. (2012) Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs. Nat. Neurosci., 15, 1488-1497.
19. Diaper, D.C., Adachi, Y., Sutcliffe, B., Humphrey, D.M., Elliott, C.J., Stepto, A., Ludlow, Z.N., Vanden Broeck, L., Callaerts, P., Dermaut, B. et al. (2013) Loss and gain of Drosophila TDP-43 impair synaptic efficacy and motor control leading to age-related neurodegeneration by loss-of-function phenotypes. Hum. Mol. Genet., 22, 1539-1557.
20. Arnold, E.S., Ling, S.C., Huelga, S.C., Lagier-Tourenne, C., Polymenidou, M., Ditsworth, D., Kordasiewicz, H.B., McAlonis-Downes, M., Platoshyn, O., Parone, P.A. et al. (2013) ALS-linked TDP-43 mutations produce aberrant RNA splicing and adult-onset motor neuron disease without aggregation or loss of nuclear TDP-43. Proc. Natl Acad. Sci. USA, 110, E736-745.
21. Buratti, E., Dörk, T., Zuccato, E., Pagani, F., Romano, M. and Baralle, F.E. (2001) Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping. EMBO J., 20, 1774-1784.
22. Sorarú, G., Orsetti, V., Buratti, E., Baralle, F., Cima, V., Volpe, M., Düascenzo, C., Palmieri, A., Koutsikos, K., Pegoraro, E. and Angelini, C. (2010) TDP-43 in skeletal muscle of patients affected with amyotrophic lateral sclerosis. Amyotroph. Lateral Scler., 11, 240-243.
23. Ince, P.G., Highley, J.R., Kirby, J., Wharton, S.B., Takahashi, H., Strong, M.J. and Shaw, P.J. (2011) Molecular pathology and genetic advances in amyotrophic lateral sclerosis: an emerging molecular pathway and the significance of glial pathology. Acta Neuropathol., 122, 657-671.
24. Brettschneider, J., Toledo, J.B., Van Deerlin, V.M., Elman, L., McCluskey, L., Lee, V.M. and Trojanowski, J.Q. (2012) Microglial activation correlates with disease progression and upper motor neuron clinical symptoms in amyotrophic lateral sclerosis. PLoS One, 7, e39216.
25. Nishihira, Y., Tan, C.F., Onodera, O., Toyoshima, Y., Yamada, M., Morita, T., Nishizawa, M., Kakita, A. and Takahashi, H. (2008) Sporadic amyotrophic lateral sclerosis:two pathological patternsshownby analysis of distribution of TDP-43-immunoreactive neuronal and glial cytoplasmic inclusions. Acta Neuropathol., 116, 169-182.
26. Weihl, C.C., Temiz, P., Miller, S.E., Watts, G., Smith, C., Forman, M., Hanson, P.I., Kimonis, V. and Pestronk, A. (2008) TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia. J. Neurol. Neurosurg. Psychiatry, 79, 1186-1189.
27. Zhang, H., Tan, C.F., Mori, F., Tanji, K., Kakita, A., Takahashi, H. and Wakabayashi, K. (2008) TDP-43-immunoreactive neuronal and glial inclusions in the neostriatum in amyotrophic lateral sclerosis with and without dementia. Acta Neuropathol., 115, 115-122.
28. Olivé, M., Janué, A., Moreno, D., Gámez, J., Torrejón-Escribano, B. and Ferrer, I. (2009) TAR DNA-binding protein 43 accumulation in protein aggregate myopathies. J. Neuropathol. Exp. Neurol., 68, 262-273.
29. Johnson, J.O., Mandrioli, J., Benatar, M., Abramzon, Y., Van Deerlin, V.M., Trojanowski, J.Q., Gibbs, J.R., Brunetti, M., Gronka, S., Wuu, J. et al. (2010) Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron, 68, 857-864.
30. Campbell, G., Göring, H., Lin, T., Spana, E., Andersson, S., Doe, C.Q. and Tomlinson, A. (1994) RK2, a glial specific homeodomain protein required for embryonic nerve cord condensation and viability in Drosophila. Development, 120, 2957-2966.
31. Xiong, W., Okano, H., Patel, N., Blendy, J. and Montell, C. (1994) Repo encodes a glial-specific homeo domain protein required in the Drosophila nervous system. Genes Dev., 8, 981-994.
32. Halter, D.A., Urban, J., Rickert, C., Ner, S.S., Ito, K., Travers, A.A. and Technau, G.M. (1995) The homeobox gene repo is required for the differentiation and maintenance of glia function in the embryonic nervous system of Drosophila melanogaster. Development, 121, 317-332.
33. Sepp, K.J., Schulte, J. and Auld, V.J. (2001) Peripheral glia direct axon guidance across the CNS/PNS transition zone. Dev. Biol., 238, 47-63.
34. Vanden Broeck, L., Naval-Sánchez, M., Adachi, Y., Diaper, D., Dourlen, P., Chapuis, J., Kleinberger, G., Gistelinck, M.,Van Broeckhoven, C., Lambert, J.C. et al. (2013) TDP-43 Loss-of-function causes neuronal loss due to defective steroid receptor-mediated gene program switching in Drosophila. Cell Rep., 3, 160-172.
35. Schnorrer, F., Schönbauer, C., Langer, C.C., Dietzl, G., Novatchkova, M., Schernhuber, K., Fellner, M., Azaryan, A., Radolf, M., Stark, A., Keleman, K. and Dickson, B.J. (2010) Systematic genetic analysis of muscle morphogenesis and function in Drosophila. Nature, 464, 287-291.
36. Dietzl, G., Chen, D., Schnorrer, F., Su, K.C., Barinova, Y., Fellner, M., Gasser, B., Kinsey, K., Oppel, S., Scheiblauer, S. et al. (2007) A genome-wide transgenic RNAi library for conditional gene inactivation in Drosophila. Nature, 448, 151-156.
37. Coulom, H. and Birman, S. (2004) Chronic exposure to rotenone models sporadic Parkinsonüs disease in Drosophila melanogaster. J. Neurosci., 24, 10993-10998.
38. White, K.E., Humphrey, D.M. and Hirth, F. (2010) The dopaminergic system in the aging brain of Drosophila. Front. Neurosci., 4, 205.
39. Humphrey, D.M., Parsons, R.B., Ludlow, Z.N., Riemensperger, T., Esposito, G., Verstreken, P., Jacobs, H.T., Birman, S. and Hirth, F. (2012) Alternative oxidase rescues mitochondria-mediated dopaminergic cell loss in Drosophila. Hum. Mol. Genet., 21, 2698-712.
40. Nalbandian,A.,Donkervoort,S.,Dec, E.,Badadani,M.,Katheria, V.,Rana,P., Nguyen, C.,Mukherjee, J., Caiozzo, V.,Martin, B. et al. (2011) The multiple faces of valosin-containing protein-associated diseases: inclusion body myopathy with Pagetüs disease of bone, frontotemporal dementia, and amyotrophic lateral sclerosis. J. Mol. Neurosci., 45, 522-531.
41. Cleveland, D.W. and Rothstein, J.D. (2001) From Charcot to Lou Gehrig:deciphering selective motor neuron death in ALS. Nat. Rev. Neurosci., 2, 806-819.
42. Foran, E. and Trotti, D. (2009) Glutamate transporters and the excitotoxic path to motor neuron degeneration in amyotrophic lateral sclerosis. Antioxid. Redox Signal, 11, 1587-1602.
43. Kim,K.,Lee,S.G.,Kegelman,T.P.,Su,Z.Z.,Das,S.K.,Dash,R.,Dasgupta,S., Barral, P.M., Hedvat, M., Diaz, P. et al. (2011) Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics. J. Cell Physiol., 226, 2484-2493.
44. Besson, M.T., Soustelle, L. and Birman, S. (1999) Identification and structural characterization of two genes encoding glutamate transporter homologues differently expressed in the nervous system of Drosophila melanogaster. FEBS Lett., 443, 97-104.
45. Ayala, Y.M., De Conti, L., Avendaño-Vázquez, S.E., Dhir, A., Romano, M., DüAmbrogio, A., Tollervey, J., Ule, J., Baralle, M., Buratti, E. and Baralle, F.E. (2011) TDP-43 regulates its mRNAlevels through a negative feedback loop. EMBO J., 30, 277-288.
46. Igaz, L.M., Kwong, L.K., Lee, E.B., Chen-Plotkin, A., Swanson, E., Unger, T., Malunda, J., Xu, Y., Winton, M.J., Trojanowski, J.Q. and Lee, V.M. (2011) Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice. J. Clin. Invest., 121, 726-738.
47. Schmid, B., Hruscha, A., Hogl, S., Banzhaf-Strathmann, J., Strecker, K., van der Zee, J., Teucke, M., Eimer, S., Hegermann, J., Kittelmann, M. et al. (2013) Loss of ALS-associated TDP-43 in zebrafish causes muscle degeneration, vascular dysfunction, and reduced motor neuron axon outgrowth. Proc. Natl Acad. Sci. USA. (in press).
48. Muntoni, F., Torelli, S. and Ferlini, A. (2003) Dystrophin and mutations: one gene, several proteins, multiple phenotypes. Lancet Neurol., 2, 731-740.
49. Burghes, A.H. and Beattie, C.E. (2009) Spinal muscular atrophy:whydo low levels of survival motor neuron protein make motor neurons sick? Nat. Rev. Neurosci., 10, 597-609.
50. Bose, J.K., Wang, I.F., Hung, L., Tarn, W.Y. and Shen, C.K. (2008) TDP-43 overexpression enhances exon 7 inclusion during the survival of motor neuron pre-mRNA splicing. J. Biol. Chem., 283, 28852-28859.
51. Miller, D.W., Cookson, M.R. and Dickson,D.W. (2004) Glial cell inclusions and the pathogenesis of neurodegenerative diseases. Neuron Glia Biol., 1, 13-21.
52. Boillée, S., Vande Velde, C. and Cleveland, D.W. (2006) ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron, 52, 39-59.
53. Serio, A., Bilican, B., Barmada, S.J., Ando, D.M., Zhao, C., Siller, R., Burr, K., Haghi, G., Story, D., Nishimura, A.L. et al. (2013) Astrocyte pathology and the absence of non-cell autonomy in an induced pluripotent stem cell model of TDP-43 proteinopathy. Proc. Natl Acad. Sci. USA. (in press).
54. Estes, P.S., Daniel, S.G., McCallum, A.P., Boehringer, A.V., Sukhina, A.S., Zwick, R.A. and Zarnescu, D.C. (2013) Motor neurons and glia exhibit specific individualized responses to TDP-43 expression in a Drosophila model of amyotrophic lateral sclerosis. Dis. Model Mech. (in press).
55. Hirth, F. (2010) Drosophila melanogaster in the study of human neurodegeneration. CNS Neurol. Disord. Drug Targets, 9, 504-523.
56. Sasaki, S., Komori, T. and Iwata, M. (2000) Excitatory amino acid transporter 1 and 2 immunoreactivity in the spinal cord in amyotrophic lateral sclerosis. Acta Neuropathol., 100, 138-144.
57. Lin, C.L.,Bristol,L.A., Jin, L.,Dykes-Hoberg,M., Crawford,T., Clawson, L. and Rothstein, J.D. (1998) Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis. Neuron, 20, 589-602.
58. Meyer, T., Fromm, A., Münch, C., Schwalenstöcker, B., Fray, A.E., Ince, P.G., Stamm, S., Grön, G., Ludolph, A.C. and Shaw, P.J. (1999) TheRNAof the glutamate transporter EAAT2 is variably spliced in amyotrophic lateral sclerosis and normal individuals. J. Neurol. Sci., 170, 45-50.
59. Flomen, R. and Makoff, A. (2011) Increased RNA editing in EAAT2 pre-mRNA from amyotrophic lateral sclerosis patients: involvement of a cryptic polyadenylation site. Neurosci. Lett., 497, 139-143.
60. Brent, J.R., Werner, K.M. and McCabe, B.D. (2009) Drosophila larvalNMJ dissection. J. Vis. Exp., 24, e1107.
61. Straw, A.D. and Dickinson, M.H. (2009) Motmot, an open-source toolkit for realtime video acquisition and analysis. Source Code Biol. Med., 4, 5.
62. Branson, K., Robie, A.A., Bender, J.A., Perona, P. and Dickinson, M.H. (2009) High-throughput ethomics in large groups of Drosophila. Nat. Methods, 6, 451-457.